Cytochroma's Series B Round

Cytochroma raised a round of funding on October 29, 2001.

Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products to treat and prevent the clinical consequences of vitamin D insufficiency and SHPT as…

Articles about Cytochroma's Series B Round: